SEC and FDA Enter Into Memorandum of Understanding

The SEC has announced that it has entered into a Memorandum of Understanding (MoU) with the Food and Drug Administration (FDA). The MoU is “designed to assist the agencies in carrying out their respective missions of ensuring the integrity of the financial markets and protecting public health.” Specifically, it establishes “a framework to support the parties’ respective regulatory and enforcement responsibilities and otherwise enhance cooperation.” For more information, see the press release on the SEC’s Web site.